+987.9%
MRNA vs RPRX
+85.8%
+902.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RPRX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.7% | +11.4% | +10.1% |
| 7D | +20.6% | +4.2% | +16.4% | +12.7% |
| 30D | +27.1% | +19.2% | +7.9% | -8.6% |
| 3M | +353.4% | +18.0% | +335.4% | +268.1% |
| 6M | +446.3% | +35.7% | +410.5% | +304.1% |
| YTD | +776.2% | +77.2% | +698.9% | +453.5% |
| 1Y | +987.9% | +82.0% | +905.9% | +581.3% |
| All | +987.9% | +85.8% | +902.1% | +581.3% |
Cumulative growth
Daily Returns
Daily percentage return beside RPRX.
Daily Out/Under-Performance
Portfolio return minus RPRX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling